Dibucaine base
Dibucaine base Brand names, Dibucaine base Analogs
Dibucaine base Brand Names Mixture
- No information avaliable
Dibucaine base Chemical_Formula
C21H27NO
Dibucaine base RX_link
No information avaliable
Dibucaine base fda sheet
Dibucaine base msds (material safety sheet)
Dibucaine base Synthesis Reference
No information avaliable
Dibucaine base Molecular Weight
309.445 g/mol
Dibucaine base Melting Point
No information avaliable
Dibucaine base H2O Solubility
No information avaliable
Dibucaine base State
Solid
Dibucaine base LogP
4.86
Dibucaine base Dosage Forms
Tablets for oral administration (25 mg, 50 mg)
Dibucaine base Indication
For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.
Dibucaine base Pharmacology
No information avaliable
Dibucaine base Absorption
Well absorbed from gastrointestinal tract following oral administration.
Dibucaine base side effects and Toxicity
Symptoms of overdose include drowsiness (severe); shortness of breath or troubled breathing; unusual tiredness or weakness (severe).
Dibucaine base Patient Information
No information avaliable
Dibucaine base Organisms Affected
Humans and other mammals
